Stanley Druckenmiller's NAMS Position
Newamsterdam Pharma Company — 6 quarters of data (Q3 2024 to Q4 2025)
Current Shares
3.07M
Current Value
$107.70M
Peak Shares
3.07M
Q4 2025
Overall Change
+968%
Shares Over Time
Q3 2024
287.5K
Q4 2024
287.5K
0%
Q1 2025
800.4K
+178%
Q2 2025
832.2K
+4%
Q3 2025
1.92M
+131%
Q4 2025
3.07M
+60%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change | Shares Δ |
|---|---|---|---|---|---|
| Q4 2025 2026-02-17 | 3.07M | $107.70M | $35.08 | +60% | +1.15M |
| Q3 2025 2025-11-14 | 1.92M | $54.71M | $28.44 | +131% | +1.09M |
| Q2 2025 2025-08-15 | 832.2K | $15.07M | $18.11 | +4% | +31.8K |
| Q1 2025 2025-05-15 | 800.4K | $16.38M | $20.47 | +178% | +512.8K |
| Q4 2024 2025-02-14 | 287.5K | $7.39M | $25.70 | 0% | 0 |
| Q3 2024 2024-11-14 | 287.5K | $4.77M | $16.60 | New | - |